Anaplasma phagocytophilum
From IDWiki
Anaplasma phagocytophilum / (Redirected from Human granulocytotropic anaplasmosis)
Background
- Causes human granulocytotropic anaplasmosis
Microbiology
- Small, obligate intracellular Gram-negative bacterium
- Related to Ehrlichia and Rickettsiae
- Tropism for neutrophils
Epidemiology
- Transmitted by Ixodes scapularis and Ixodes pacificus ticks
- Rare case reports in Ontario
- Transmission may take as little as 24 hours of tick attachment
Clinical Manifestations
- Incubation period of 1 to 2 weeks
- Usually an acute undifferentiated fever
- Can be mild or severe
- Fever, headache, malaise, and myalgias are common
- Can also cause nausea, vomiting, diarrhea, cough, arthralgias, nuchal rigidity, and confusion
- Less than 10% have rash, most of which is concurrent Lyme disease
- 36% of cases require hospitalization, and it is severe in 3 to 7%
- Severe complications include respiratory failure, septic shock, rhabdomyolysis, hemorrhage, and opportunistic infections
- Rare meningoencephalitis
- Higher case-fatality rate in Shandong Province in China, for no clear reason (16% versus 2.6%)
- Thrombocytopenia, leukopenia, and mild anemia are common
- Return to normal range within 14 days, but with persistent left shift
- Abnormal liver enzymes are common in the first 7 days
Diagnosis
- 20-80% of patients will have circulating neutrophils with detectable morulae on blood film (in neutrophils/granulocytes)
- Serology used to diagnose, by measuring IgG levels ≥1:64 or a fourfold rise
- IgM testing less sensitive and specific
- Culture not done routinely
- PCR possible
Management
- Doxycycline 100 mg po bid until at least 72 days after defervescence
- Possibly 10 days if risk of concurrent Lyme disease